Gene therapy of experimental autoimmune thyroiditis mice by in vivo administration of plasmid DNA coding for human interleukin-10

Acta Pharmacologica Sinica

Volumn 24, Issue 9, 2003, Pages 885-890+949

  Zhang, Zhen Lin ^a,b,c   Lin, Bo ^b   Yu, Lu Yang ^b   Shen, Shui Xian ^c   Zhu, Li Hua ^b   Wang, Wui Ping ^c   Guo, Li He ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Autoimmune diseases; Gene therapy; Interleukin 10; Thyroiditis

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; MESSENGER RNA; PLASMID DNA; POLYLYSINE; THYROGLOBULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL STRAIN COS7; CONTROLLED STUDY; DISEASE COURSE; DNA TRANSFECTION; EXPRESSION VECTOR; FEMALE; GENE; GENE THERAPY; GENE TRANSFER; HASHIMOTO DISEASE; HISTOPATHOLOGY; IMMUNIZATION; INTERLEUKIN 10 GENE; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; THYROID GLAND;

ANIMALS; COS CELLS; DISEASE MODELS, ANIMAL; DNA FRAGMENTATION; FEMALE; GENE THERAPY; GENETIC VECTORS; INTERFERON TYPE II; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; PLASMIDS; RNA, MESSENGER; THYROGLOBULIN; THYROID GLAND; THYROIDITIS, AUTOIMMUNE; TRANSFECTION;

EID: 0042819750     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Vanderpump MPJ, Tunbrige WMG, French JM. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol 1995; 43: 55-68.
2. Ricci-Vitiani L, Conticello C, Zeuner A, Maria RD. CD95/CD95L interactions and their role in autoimmunity. Apoptosis 2000; 5: 419-24.
3. Weetman AP, Mcgregor AM. Autoimmune thyroid disease: Further developments in our understanding. Endocr Rev 1994; 15: 788-830.
4. Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. N Engl J Med 1996; 335: 99-107.
5. Giordano C, Stassi G, Maria RD, Todaro M, Richiusa P, Papoff G. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science 1997; 275: 960-3.
6. Simon LL, Justen JM, Giraldo AA. Activation of cytotoxic T cells and effector cells in experimental autoimmune thyroiditis by shared determinants of mouse and human thyroglobulin. Clin Immunol Immunopathol 1986; 39: 345-56.
7. Mignon-Godefroy K, Rott O, Brazillet MP, Charreire J. Curative and protective effects of IL-10 in experimental autoimmune thyroiditis (EAT): evidence for IL-10-enhanced cell death in EAT. J Immunol 1995; 154: 6634-43.
8. Atkins MB, Gould JA, Allegretta M. Phase I evaluation of recombinant interleukin-2 in patients with advanced malignant disease. J Clin Oncol 1986; 4: 1380-91.
9. Batteux F, Tourneur L, Trebeden h, Charreire J, Chiocchia G. Gene therapy of experimental autoimmune thyroiditis by in vivo administration of plasmid DNA coding for Fas ligand. J Immunol 1999; 162: 603-8.
10. Zhang ZL, Sheng SX, Lin Bo, Yu LY, Zhu LH,Wang HP, et al. Intramuscular injection of interleukin-10 plasmid DNA prevented autoimmune diabetes in mice. Acta Pharmacol Sin 2003; 24: 751-6.
11. Batteux F, Lores P, Bucchini D, Chiocchia G. Transgenic expression of Fas ligand on thyroid follicular cells prevents autoimmune thyroiditis. J Immunol 2000; 164: 1681-8.
12. Nicoletti F, Marco RD, Conget I, Gomis R, Edwards III C, Papaccio G, et al. Sodium fusidate ameliorates the course of diabetes induced in mice by multiple low doses of streptozotocin. J Autoimmunity 2000; 15: 395-405.
13. Chun S, Daheshia M, Lee S. Immune modulation by IL-10 transfer via viral vector and plasmid DNA: implication for gene therapy. Cell Immunol 1999; 194: 194-204.
14. Alimi E, Huang S, Brazillet MP, Charreire J. Experimental autoimmune thyroiditis (EAT) in mice lacking the IFN-γ receptor gene. Eur J Immunol 1998; 28: 201-4.
15. Tang H, Mignon-Godefroy K, Meroni PL, Garotta G, Charreire J, Nicoletti F. The effects of a monoclonal antibody to interferon-γ on experimental autoimmune thyroiditis (EAT): prevention of disease of EAT-specific T cells. Eur J Immunol 1993; 23: 275-8.
16. Mahato R, Anwer K, Tagliaferri F, Meaney C, Leonard M, Wadhwa MS, et al. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration. Hum Gene Ther 1998; 9: 2083-99.
17. Liu Y, Liggitt D, Zhong W, Tu G, Gaensler K, Debs R. Cationic liposome-mediated intravenous gene delivery. J Biol Chem 1995; 270: 24864-70.
18. Xu M, Kumar D, Shrinivas S, Detolla LJ, Yu SF, Stass SA, et al. Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity. Hum Gene Ther 1997; 8: 177-85.
19. Nabel GJ, Nabel FG, Yang ZY, Fox BA, Plautz GE, Gao X, et al. Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in human. Proc Natl Acad Sci USA 1993; 90: 11307-11.
20. Canonico AE, Plitman JD, Conary JT, Meyrick BO, Brigham KL. No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes. J Appl Physiol 1994; 77: 415-9.